Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathyTina Vilsbøll(University of Copenhagen), Michael Larsen(University of Copenhagen)Diabetes Obesity and MetabolismNovember 27, 201710.1111/dom.13172Cited by 290SaveCiteExport RISWatch citationsRelated PapersIncretins, insulin secretion and Type 2 diabetes mellitus|Diabetologia|2004|438Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis|PLoS ONE|2016|241